Valuation : Vista Pharmaceuticals Limited

Market Cap 376M 3.94M 3.39M 3.21M 2.91M 5.46M 5.49M 38.14M 14.67M 191M 14.78M 14.46M 605M P/E 2024
-10.3x
P/E 2025 -13.6x
Enterprise Value 443M 4.63M 3.99M 3.78M 3.43M 6.43M 6.46M 44.91M 17.27M 225M 17.41M 17.02M 712M EV / Sales 2024
7.63x
EV / Sales 2025 8.85x
Free-Float
22.51%
Yield 2024 *
-
Yield 2025 -
1 day+2.68%
1 week-8.44%
Current month-8.29%
1 month-16.67%
3 months-22.30%
6 months-12.75%
Current year-29.36%
1 week 5.5
Extreme 5.5
6.17
1 month 5.5
Extreme 5.5
7.28
Current year 5.5
Extreme 5.5
8.87
1 year 5.5
Extreme 5.5
10.5
3 years 5.5
Extreme 5.5
19.7
5 years 5.5
Extreme 5.5
19.7
10 years 4.51
Extreme 4.51
56.15
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer - 10/02/2024
Director TitleAgeSince
Chairman 76 02/01/2014
Director/Board Member 87 16/06/1993
Director/Board Member 76 02/02/2010
Change 5-day change 1-year change 3-year change Capi.($)
+2.68%-8.44%-41.62%-66.53% 3.7M
-1.13%-3.11%+13.82%+60.17% 46.21B
-0.79%-4.18%+32.63%+106.31% 38.78B
+0.12%-0.08%+7.12%+73.98% 11.68B
-0.53%-1.37%-13.25%+11.19% 11.55B
-0.38%-2.26%+18.18%+142.99% 9.14B
+0.32%-2.26%+23.08%+35.61% 7.3B
+0.17%-0.74%+13.44%+180.68% 7.15B
+0.30%-3.82%+33.45%-19.61% 7.1B
-3.13%-4.30%-44.88%+12.88% 4.97B
Average -0.25%-3.18%+4.20%+53.77% 14.39B
Weighted average by Cap. -0.72%-3.27%+15.84%+74.22%

Financials

2024 2025
Net sales 103M 1.08M 928K 879K 796K 1.49M 1.5M 10.43M 4.01M 52.34M 4.04M 3.96M 165M 101M 1.05M 909K 860K 780K 1.46M 1.47M 10.22M 3.93M 51.26M 3.96M 3.87M 162M
Net income -45.12M -472K -407K -385K -349K -655K -659K -4.58M -1.76M -22.96M -1.77M -1.73M -72.54M -46.49M -487K -419K -397K -360K -675K -678K -4.71M -1.81M -23.65M -1.83M -1.79M -74.73M
Net Debt 78.7M 824K 710K 672K 609K 1.14M 1.15M 7.98M 3.07M 40.04M 3.09M 3.03M 127M 66.71M 698K 602K 570K 516K 969K 974K 6.77M 2.6M 33.94M 2.62M 2.56M 107M
Logo Vista Pharmaceuticals Limited
Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).
Employees
30
Date Price Change Volume
11/09/26 ₹5.750 +2.68% 6,559
10/09/26 ₹5.600 -4.60% 26,683
09/09/26 ₹5.870 +1.21% 3,596
08/09/26 ₹5.800 -2.52% 33,779
07/09/26 ₹5.950 -5.25% 4,754
  1. Stock Market
  2. Stocks
  3. VISTAPH6 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!